9.54

7.47% -0.77

Briacell Therapeutics Corp (BCTX)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Briacell Therapeutics Corp stock is traded at $9.54, with a volume of 54,096. It is down -7.47% in the last 24 hours and down -5.64% over the past month. BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.

Previous Close:

$10.31

Open:

$10.3

24h Volume:

54,096

Relative Volume:

0.77

Market Cap:

$17.97M

Revenue:

Net Income/Loss:

$-26.56M

P/E Ratio:

-0.2157

EPS:

-44.2199

Net Cash Flow:

$-28.59M

1W Performance:

-16.24%

1M Performance:

-5.64%

6M Performance:

+170.25%

1Y Performance:

-3.81%

1-Day Range:

$9.54

$10.31

1-Week Range:

$9.54

$13.09

52-Week Range:

$0.61

$14.68

Briacell Therapeutics Corp Stock (BCTX) Company Profile

Name

Briacell Therapeutics Corp

Sector

Healthcare (1123)

Industry

Biotechnology (627)

Phone

(604) 921-1810

Address

3RD FLOOR, BELLEVUE CENTRE, 235-15TH STR, WEST VANCOUVER

Employee

Twitter

Next Earnings Date

2024-10-28

Latest SEC Filings

BCTX's Discussions on Twitter

Compare BCTX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
BCTX Briacell Therapeutics Corp	9.54	19.42M	0	-26.56M	-28.59M	-44.22
VRTX Vertex Pharmaceuticals Inc	452.04	113.14B	11.74B	3.68B	3.34B	14.19
REGN Regeneron Pharmaceuticals Inc	741.29	78.49B	14.25B	4.58B	3.88B	41.77
ARGX Argen X Se Adr	877.94	54.76B	3.06B	1.28B	447.35M	19.67
ALNY Alnylam Pharmaceuticals Inc	397.55	54.51B	3.21B	43.57M	221.36M	0.2405
INSM Insmed Inc	197.01	41.64B	447.02M	-1.18B	-906.14M	-6.1812

Briacell Therapeutics Corp Stock (BCTX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-14-22	Initiated	H.C. Wainwright	Buy

Briacell Therapeutics Corp Stock (BCTX) Latest News

Dec 13, 2025

Rally Mode: What insider trading reveals about BriaCell Therapeutics Corp stockIPO Watch & Comprehensive Market Scan Insights - moha.gov.vn

Dec 13, 2025

(BCT) Trading Performance and Risk Management (BCT:CA) - news.stocktradersdaily.com

Dec 13, 2025

Dec 11, 2025

BriaCellModel Bria-IMT and Bria-OTSDestroy Cancer Cells - Environmental XPRT

Dec 11, 2025

Dec 10, 2025

BriaCell reports positive data for breast cancer immunotherapy By Investing.com - Investing.com Nigeria

Dec 10, 2025

BriaCell (BCTX) Highlights Promising Data at 2025 SABCS Symposiu - GuruFocus

Dec 10, 2025

BriaCell Presents Outstanding Phase 2 Survival & Promising Phase 3 Clinical Data at SABCS® 2025 - Investing News Network

Dec 10, 2025

BriaCell’s Bria-IMT Shows Promising Results in Metastatic Breast Cancer Trials - TipRanks

Dec 10, 2025

BriaCell reports positive data for breast cancer immunotherapy - Investing.com India

Dec 10, 2025

BriaCell's Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout - Investing News Network

Dec 09, 2025

BriaCell’s Phase 3 Patient Enrollment on Track for 1H2026 Topline Data Readout - The Manila Times

Dec 09, 2025

Dec 07, 2025

Movement Recap: Will BriaCell Therapeutics Corp Equity Warrant stock outperform Dow Jones indexJuly 2025 Sector Moves & Expert-Curated Trade Recommendations - moha.gov.vn

Dec 07, 2025

BriaCell Therapeutics (BCTXZ) Stock Analysis Report | Financials & Insights - Benzinga

Dec 07, 2025

Dec 04, 2025

BriaCell Therapeutics : Investor Presentation (1Dec2025 Investor Presentation) - marketscreener.com

Dec 04, 2025

Will BriaCell Therapeutics Corp. Equity Warrant stock outperform Dow Jones indexQuarterly Profit Report & Long-Term Investment Growth Plans - Newser

Dec 04, 2025

Dec 02, 2025

BriaCell to present positive breast cancer therapy data at SABCS By Investing.com - Investing.com Australia

Dec 02, 2025

BriaCell Therapeutics (BCTXW) Stock Analysis Report | Financials & Insights - Benzinga

Dec 02, 2025

BriaCell Unveils Promising Clinical Data at 2025 SABCS - TipRanks

Dec 02, 2025

BriaCell to Present Phase 2 Survival & Phase 3 Clinical Data at SABCS® 2025 - Investing News Network

Dec 02, 2025

BriaCell (BCTX) Shares Positive Clinical Results Ahead of 2025 S - GuruFocus

Dec 02, 2025

BriaCell to present positive breast cancer therapy data at SABCS - Investing.com

Dec 02, 2025

Can BriaCell Therapeutics Corp. stock hit analyst price targetsMarket Risk Analysis & Free Real-Time Market Sentiment Alerts - Newser

Dec 02, 2025

Dec 01, 2025

(BCT) Strategic Investment Report (BCT:CA) - news.stocktradersdaily.com

Dec 01, 2025

Bicara Therapeutics (BCTX) Releases Promising Early Data from Ca - GuruFocus

Dec 01, 2025

BriaCell files subsidiary financials and analysis with Canadian regulators By Investing.com - Investing.com Nigeria

Dec 01, 2025

BriaCell files subsidiary financials and analysis with Canadian regulators - Investing.com

Dec 01, 2025

BriaCell Therapeutics Corp Subsidiary Files Financial Statements - TradingView

Dec 01, 2025

Nov 28, 2025

(BCT) Comprehensive Trading Strategy Report (BCT:CA) - news.stocktradersdaily.com

Nov 28, 2025

What analysts say about BriaCell Therapeutics Corp stockEquity Performance Review & Fast Growing Portfolio Trading - earlytimes.in

Nov 28, 2025

BCTXZ Insider Trading - Quiver Quantitative

Nov 28, 2025

Nov 27, 2025